http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters
-
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
-
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
-
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
-
Cytek® Biosciences (CTKB) Appoints Philippe Busque as SVP of Global Sales & Services
-
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
-
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
-
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
-
Cytek Biosciences Reports Second Quarter 2023 Financial Results
-
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
-
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
-
Cytek® Biosciences (CTKB) Announces $50M Share Buyback
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program
-
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
-
Cytek Biosciences Reports First Quarter 2023 Financial Results
-
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
-
Cytek Biosciences to Report First Quarter 2023 Financial Results on May 9, 2023
-
Cytek® Biosciences Introduces New 20-Color AML Panel
-
Cytek® Biosciences Introduces New 20-Color AML Panel
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
-
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
-
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
-
Cytek® Biosciences (CTKB) to Acquire Flow Cytometry and Imaging Business from DiaSorin
-
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
-
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
-
Cytek Biosciences (CTKB) Partners with Bio-Rad to Expand Reagent Portfolios
-
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
-
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
-
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
-
Cytek Biosciences (CTKB) Introduces Cytek Cloud
-
Cytek® Biosciences Introduces Cytek Cloud
-
Cytek® Biosciences Introduces Cytek Cloud
-
Cytek Biosciences Reports Third Quarter 2022 Financial Results
-
Cytek Biosciences Reports Third Quarter 2022 Financial Results
-
Cytek® Biosciences (CTKB) Names Chris Williams Chief Operating Officer
-
Cytek® Biosciences Names Chris Williams Chief Operating Officer
-
Cytek® Biosciences Names Chris Williams Chief Operating Officer
-
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
-
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
-
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
-
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
-
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
-
Cytek Biosciences Reports Second Quarter 2022 Financial Results

